NAMS - NewAmsterdam Pharma Company N.V.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.00
DETAILS
HIGH:
$55.00
LOW:
$37.00
MEDIAN:
$46.00
CONSENSUS:
$46.00
UPSIDE:
29.80%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 99.7% |
| EBIT Margin | -1077.8% |
| EBITDA Margin | -1076.9% |
| Operating Margin | -1002.9% |
| Pretax Margin | -905.7% |
| Cont. Ops Margin | -905.7% |
| Net Margin | -905.7% |
| Bottom Line Margin | -905.7% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 7.88 |
| Quick Ratio | 7.88 |
| Solvency Ratio | -2.371 |
| Cash Ratio | 5.71 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-19.69
Peers avg: 17.0
|
| PEG Ratio | 0.62 |
| Forward PEG | 0.62 |
| Price/Book | 5.87 |
| Price/Sales | 178.34 |
| Price/FCF | -27.11 |
| Price/Op Cash Flow | -27.16 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0003 |
| Debt/Equity | 0.0003 |
| Debt/Capital | 0.0003 |
| Long-Term Debt/Capital | 0.0001 |
| Financial Leverage | 1.13 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.03 |
| Operating Cash Flow Ratio | -1.723 |
| Operating Cash Flow/Sales | -656.7% |
| Free Cash Flow/Operating Cash Flow | 100.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -1781.80 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -1086.64 |
| Operating Cash Flow Coverage | -731.60 |
| Capital Expenditure Coverage | -600.74 |
| Dividend + Capital Expenditure Coverage | -600.74 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.20 |
| EPS | -1.782 |
| Debt/Share | 0.0018 |
| Cash/Share | 5.56 |
| Book Value/Share | 5.97 |
| Tangible BV/Share | 5.97 |
| Equity/Share | 5.97 |
| Operating Cash Flow/Share | -1.292 |
| Capital Expenditure/Share | 0.002 |
| FCF/Share | -1.294 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.903 |
| Price/Fair Value | 5.87 |
| Debt/Market Cap | 0.0001 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -14.54 |